ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,615.35
0.55%
US Tech 100
19,804.00
0.64%
Dow Jones
40,000.90
0.62%
Brent Oil
84.57
0.00%
Bitcoin
60,026.70
1.34%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Balyo S.A. (BALYO) Quote

Balyo S.A.

Balyo S.A. (BALYO)

EU
0.517
0.007
(1.37%)
Closed July 14 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.517
Bid
0.49
Ask
0.517
Volume
247
0.492 Day's Range 0.52
0.4405 52 Week Range 0.85
Market Cap
17.522M
Previous Close
0.51
Open
0.52
Last Trade
1
@
0.517
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,930
Shares Outstanding
34,356,767
Dividend Yield
-
PE Ratio
-1.83
Earnings Per Share (EPS)
-0.28
Revenue
26.67M
Net Profit
-9.76M

About Balyo S.A.

Sector
Indl, Coml Machy, Equip, Nec
Industry
Indl, Coml Machy, Equip, Nec
Website
www.balyo.com
Headquarters
L'hay-les-roses, Val-de-marne, Fra
Founded
1970
Balyo S.A. is listed in the Indl, Coml Machy, Equip sector of the Euronext with ticker BALYO. The last closing price for Balyo was 0.51 €. Over the last year, Balyo shares have traded in a share price range of 0.4405 € to 0.85 €.

Balyo currently has 34,356,767 shares outstanding. The market capitalization of Balyo is 17.52 € million. Balyo has a price to earnings ratio (PE ratio) of -1.83.

BALYO Latest News

More News

BALYO : Mise à disposition des documents et renseignements relatifs à l’Assemblée générale mixte du 13 juin 2024

Regulatory News: BALYO (FR0013258399, Mnémonique : BALYO, éligible PEA-PME), leader technologique dans la conception et le développement de solutions robotisées innovantes pour les chariots de...

May 23 2024
Business Wire

BALYO : Mise à disposition du Document d’Enregistrement Universel 2023

Regulatory News: BALYO (FR0013258399, Mnémonique : BALYO, éligible PEA-PME), leader technologique dans la conception et le développement de solutions robotisées innovantes pour les chariots de...

April 26 2024
Business Wire

BALYO annonce son chiffre d’affaires du 1er trimestre 2024, à 5,2 M€

Chiffre d’affaires du T1 2024 à 5,2 M€, en baisse de -27% vs. T1 2023 Forte progression du carnet de commandes1 à 19 M€ au T1 2024, en hausse de +35% vs. T1 2023 Mise en place d’un prêt...

April 23 2024
Business Wire

BALYO annonce ses résultats annuels 2023

Chiffre d’affaires 2023 à 26,7 M€, +10% vs. 2022 Prises de commandes 2023 en croissance de +39% vs. 2022, à 36,1 M€ Hausse des ventes directes à 58% des prises de commandes 2023 vs. 37% en 2022...

March 21 2024
Business Wire

BALYO Announces Its Revenues for 2023, up by +10% at €26.7 Million and Q4 Order Intake Growth of +68% to €17.8 Million

Growth in 2023 order intake by +39% vs. 2022, to €36.1 million, with a significant order intake of $7.8 million in the United States recorded in Q4 Increase in the share of direct sales...

January 30 2024
Business Wire

Communiqué établissant le bilan semestriel du contrat de liquidité entre BALYO et NATIXIS ODDO BHF

Regulatory News: Au titre du contrat de liquidité confié par BALYO (Paris:BALYO) à NATIXIS ODDO BHF, à la date du 31/12/2023 les ressources suivantes figuraient au compte de liquidité dédié : 34...

January 26 2024
Business Wire

BALYO annonce son calendrier financier pour l’exercice 2024

Regulatory News: BALYO (FR0013258399, Mnémonique : BALYO, éligible PEA-PME) (Paris:BALYO), leader technologique dans la conception et le développement de solutions robotisées innovantes pour les...

January 15 2024
Business Wire

BALYO : Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2023

Regulatory News: BALYO (Paris:BALYO) : Nombre d’actions* composant le capital en circulation 34.365.737 Nombre d’actions* bénéficiant du droit de vote double 0 Nombre d’actions* bénéficiant du...

January 10 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0173.40.50.520.482514490.50889343DE
4-0.023-4.259259259260.540.540.440545160.50307712DE
12-0.093-15.24590163930.610.6370.440549300.56594065DE
26-0.304-37.02801461630.8210.8240.440557930.66201591DE
52-0.309-37.40920096850.8260.850.4405272220.81652902DE
156-0.919-63.99721448471.4361.6780.3795975710.89752389DE
260-1.983-79.322.52.80.37951611771.28933807DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.69M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Discussion

View Full Feed
JOHNNIEBG JOHNNIEBG 4 minutes ago
it is sad that you can't even get this right. The shooters name was THOMAS CROOKS.... MAGA trying to make it look like the opposition set it up. MORE LIES

Trump rally shooter Thomas Crooks identified: What we know

https://www.msn.com/en-us/money/careersandeducation/
vator vator 8 minutes ago
There are combo trials going on with DCVax. It is called ALT DC when made in the UCLA facility. Another wrong misconception is that UCLA licenses it to NWBO. It is the reverse. NWBO owns it and allows UCLA to test, use and work with it. NWBO pays UCLA in support of this work.

And the
NWBO
MiamiGent MiamiGent 8 minutes ago
Unfortunately, she wasn't tall enough to cover President Trump. But she was right in there, on the job.
Hoghead7 Hoghead7 10 minutes ago
Feasel had the input in the beginning and the end. Few references Data centers in the most recent call and we obviously have the MOU with IBM.
FCEL
madras50 madras50 10 minutes ago
you talking about AFFL that is sitting at .03 at the moment?
AFFL
StayHumble StayHumble 10 minutes ago
Huzzah!.000001 Buys✅ w0w✅✅✅
https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades
HCMC
StayHumble StayHumble 11 minutes ago
$HCMC says Protect. Enforce. Monetize. License🟩🟩🟩

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMicroOct2022.pdf
HCMC
StayHumble StayHumble 11 minutes ago
Oink $22M+✅ASSets $55M+✅$20.4MPositiveWorkingOink✅
We believe that current oink on hand & cash flow from Oink will be sufficient to fund our working Oink and other cash requirements for at least the next 12 months. ✅


Did Oink release a Video on this Oink yet?
Wor
HCMC
XenaLives XenaLives 12 minutes ago
This is really messed up...


PERILS OF PREEMPTION
Are you aware that your ability to file a state lawsuit for harms suffered, including death, against a pharmaceutical company for failure to warn of hidden but known risks of a potential side-effect of a particular medica
StayHumble StayHumble 12 minutes ago
w0w NO R/S+MERGER AQUISITION 🟩ohBoy onDECKYowza!
https://x.com/CorporateUbqu/status/1765510100628726105?s=20
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
UBQU
StayHumble StayHumble 13 minutes ago
$UBQU Innovative outcomes already doing 5M🟩inRevenue Annually and growing, with facilities already in place to help make it happen. Just watch what we do!
https://twitter.com/CorporateUbqu/status/1767983893544566905
YEP HUZZAH! on DECK oh GIRL
https://cdn.vox-cdn.com/upl
UBQU
kemsma62 kemsma62 14 minutes ago
It came out on Friday!

https://www.sec.gov/Archives/edgar/data/1885408/000121390024061019/ea0209068-6k_jeffsbrands.htm
JFBR
doc2016 doc2016 15 minutes ago
aws secrets agent.........vcsy personal secret place?
use dynamic dns to obtain the local/regional address and the 8x8 patent for dynamic dns mapping into your own network.
https://docs.aws.amazon.com/secretsmanager/latest/userguide/secrets-manager-agent.html
StayHumble StayHumble 16 minutes ago
This SEC Stock Hoax is Shot 🚩🚩🚩

DJT
prototype_101 prototype_101 24 minutes ago
Lebby ASM at 12:40 "Our Foundry RESULTS that we presented back in March are 200Gb per lane, but really got the Industry excited is that we did it at 1 volt, so we did it at WORLD CLASS PERFORMANCE!! and clearly we're going to be challenged to this very, very quickly!! Then what we also did with coll
ASM LWLG
StayHumble StayHumble 26 minutes ago
This SEC Stock Hoax is Shot 🚩🚩🚩
https://decider.com/wp-content/uploads/2020/06/ancient-aliens.jpg?quality=75&strip=all
StayHumble StayHumble 27 minutes ago
this DJT Stock is a Mess🚩🚩🚩
https://decider.com/wp-content/uploads/2020/06/ancient-aliens.jpg?quality=75&strip=all
fuzzy fuzzy 27 minutes ago
5-11-17-22...thanks
StayHumble StayHumble 28 minutes ago
w0w Kramer improperlyBOT 2bill+LaidlawEGroupShares & sold them to investors(2006-2010)
Source: https://www.reuters.com/article/us-sec-pennystock-settlement-idUSBRE9AO11420131125 Facts Kramer BOT&sold 1bill+ unregistered BederraCorp Shares that had been misappropriated by that company’s
DBMM GTII HPIL
manibiotech manibiotech 29 minutes ago
Facts are inconvenient .

An oncologist will almost never say that cancer is cured , maybe for very very few cancers . But some here are use the term so nonchalantly and that too for GBM , it’s quite amazing

From :

https://www.cancer.gov/about-cancer/diag
NWBO
IU IU 30 minutes ago
Annualized PE ratio very Low!! (~10) Very good for high growth company
Price to Earnings (P/E) Ratio
Net Income: $158,034 for the first quarter.
Annualized Net Income: Assuming constant quarterly earnings, $158,034 * 4 = $632,136.
P/E Ratio:
Market Cap
Annu
LBRG
StayHumble StayHumble 31 minutes ago
w0wXcellent✅Kramers 100% Involved✅BillionsNakedSH0rt ???

It explains the situation about shorting and naked shorting perfectly!

Again, this is a MUST WATCH video for anyone who believes in $DBMM (naked or otherwise)!

I'd love to hear a
AMC BBBY CRTD
edbi46 edbi46 32 minutes ago
NOPAIN Act
Jan. 1, 2025

https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

Just to highlight a few points::

(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—
SAI WBA
JOHNNIEBG JOHNNIEBG 39 minutes ago
You are as sick as the ones who want to kill TRUMP...........

Your Recent History

EU
BALYO
Balyo
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved